Canagliflozin Medications

Canagliflozin Info

What Is Canagliflozin?

Canagliflozin is a medication that belongs to a group called sodium-glucose co-transport-2 (SGLT-2) inhibitors. It helps lower blood sugar by encouraging the kidneys to remove excess glucose through urine. This active ingredient is used in several products, most notably the prescription medicine Invokana.

Medications with Canagliflozin

In the United Kingdom, the primary brand that contains canagliflozin is Invocado (known internationally as Invokana). It is available as oral tablets in strengths of 100 mg and 300 mg. The drug is marketed by Janssen Pharmaceuticals and is supplied in generic form as well as the branded product. While Invocado is the most common preparation, other brands using the same active ingredient may appear under different names if they are imported or prescribed through specialist channels.

What Does Canagliflozin Treat?

• Type 2 diabetes - Canagliflozin is used to improve blood-glucose control in adults with type 2 diabetes, often alongside diet, exercise, and other diabetes medicines.
• Heart-failure management - Certain clinical guidelines include canagliflozin as a therapy to reduce the risk of hospitalization for heart failure in people with reduced ejection fraction.
• Chronic kidney disease - Evidence supports its use to slow the progression of kidney disease in patients with type 2 diabetes and established renal impairment.

These uses are based on approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and reflect the drug’s ability to lower glucose and provide protective effects on the heart and kidneys.

How Canagliflozin Works

Canagliflozin blocks the SGLT-2 proteins in the kidney’s tiny filtering units. When these proteins are inhibited, less glucose is re-absorbed back into the bloodstream, so excess sugar is expelled in the urine. This results in lower blood-sugar levels within a few days of starting treatment. Because the action is outside the bloodstream, it does not depend on insulin, making it useful for people whose bodies do not respond well to insulin. The effect on glucose excretion is steady, and the drug does not build up in the body over time.

Safety Information

Common Side Effects

• Increased urination and a mild change in the taste of urine are frequently reported.
• Some people notice a small amount of weight loss due to water loss and calorie loss through glucose in the urine.
• Mild genital yeast infections can occur, especially in women, because of the higher sugar content of the urine.

These effects are usually temporary and resolve without medical intervention.

Serious Reactions

• Severe allergic reactions - Symptoms may include swelling of the face, lips, or tongue, difficulty breathing, or a rash that spreads quickly.
• Low blood-sugar (hypoglycaemia) - While canagliflozin alone rarely causes hypoglycaemia, it can happen when combined with insulin or sulfonylureas. Signs include shakiness, sweating, or confusion.
• Kidney problems - A sudden drop in kidney function may be signalled by reduced urine output or swelling in the legs.

If any of these signs appear, seek urgent medical attention.

Who Should Be Cautious

• People with severe kidney impairment (eGFR < 30 mL/min/1.73 m²) are generally advised against using canagliflozin.
• Those who are pregnant, planning a pregnancy, or breastfeeding should avoid the drug, as safety data are limited.
• Individuals with a history of recurrent urinary or genital infections should discuss alternative options with their prescriber.

Interaction Awareness

Canagliflozin can interact with several other medication classes:

• Diuretics - May increase the risk of dehydration and low blood-pressure.
• Insulin or sulfonylureas - Can raise the chance of hypoglycaemia.
• Blood-pressure-lowering drugs - May cause an additive drop in blood pressure.

Alcohol consumption can amplify dehydration, while certain high-carb meals may affect glucose-excretion benefits. For a complete list of possible interactions, refer to the specific product’s information sheet.

What to Know Before Using

Store tablets in a cool, dry place away from direct sunlight and out of reach of children. Typical treatment periods range from a few weeks for initial blood-glucose control to long-term use for heart-failure or kidney protection. Remember that different brands or strengths of canagliflozin may have slightly different instructions - always follow the guidance provided with the particular medicine you have. For detailed usage, dosing, and administration, consult the individual medication’s label.

Information Disclaimer

This article offers general educational information about canagliflozin as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing canagliflozin may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.